Atlas Trials

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Clinical trial NCT00101257 · COMPLETED

Trial details

NCT number
NCT00101257
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian CancerPeritoneal Cavity Cancer
Start date
2004-10-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.